Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Open in API
Filings indexed 1,124 across all filing types
Latest filing 2014-05-28 Earnings Release
Country SE Sweden
Listing ST EKTA

About Elekta

https://www.elekta.com/

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Earnings Release 2014
Earnings Release Classification · 1% confidence The document is titled "Bokslutskommuniké maj – april 2013/14" (Year-end report communication May – April 2013/14) and contains detailed financial summaries for a 12-month period, including key metrics like Net Sales (Nettoomsättning), EBITA, Net Income (Periodens resultat), and Earnings Per Share (Vinst per aktie). It also includes management commentary, outlook statements, and comparative tables covering the full fiscal year. This structure is characteristic of a comprehensive annual financial report or a detailed year-end earnings release that often accompanies or precedes the formal 10-K filing. Given the depth of the financial data, forward-looking statements, and the explicit reference to the full fiscal year ('12 månader maj - apr'), it strongly aligns with the content of an Annual Report (10-K) or a very detailed Interim/Quarterly Report (IR) covering the full year. Since it covers the full fiscal year and provides extensive detail, it is most appropriately classified as the content typically found in an Annual Report (10-K) or a comprehensive year-end report, which often serves as the basis for the 10-K. However, since the text is a 'Bokslutskommuniké' (Year-end Communication) and not explicitly labeled as the 10-K form itself, and it contains management discussion and analysis (MDA) elements, the best fit among the provided codes for a comprehensive annual financial disclosure is 10-K, assuming this is the primary annual filing document, or potentially MDA if it were purely narrative. Given the extensive financial tables and year-end focus, 10-K is the strongest fit for the *type* of information presented, even if the specific document name is a local equivalent. If we must choose between the specific codes, and recognizing this is the full annual performance review, 10-K is the closest match for comprehensive annual results. FY 2014
2014-05-28 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is a 'Year-end report' for the fiscal year 2013/14, containing comprehensive financial statements, regional performance analysis, CEO comments, and outlook. It provides detailed financial data (order bookings, net sales, EBITA, net income, cash flow) for both the 3-month and 12-month periods. It is not a mere announcement (RPA) or a summary, but the full interim/annual financial report for the period, fitting the definition of an Interim/Quarterly Report (IR) as it covers the fiscal year-end performance. FY 2014
2014-05-28 English
Förändringar i Elektas koncernledning
Board/Management Information Classification · 1% confidence The document text is titled 'Förändringar i Elektas koncernledning' (Changes in Elekta's Group Management) and explicitly announces the appointment of two individuals, Åsa Hedin and Maurits Wolleswinkel, to Executive Vice President roles, noting they will become members of the group management. This directly corresponds to the definition of Board/Management Information, which covers announcements of changes in senior management.
2014-05-08 Swedish
Elekta announces changes to its Executive Management team
Board/Management Information Classification · 1% confidence The document explicitly announces changes to the company's Executive Management team, naming new Executive Vice Presidents (EVPs) and detailing their new roles and reporting structures. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2014-05-08 English
Elekta announces strategic partnership with the Centre hospitalier de l’Université de Montréal
Regulatory Filings Classification · 1% confidence The document announces a specific business event: a strategic partnership and a large order for cancer treatment equipment from a hospital (CHUM). It details the value (USD 20 million) and the booking period (Q4 FY 2013/14). This is a material, non-financial announcement concerning business operations and contracts, rather than a standard periodic financial report (like 10-K or IR), a management discussion (MDA), or a formal earnings release (ER). It is a specific corporate action announcement. Since there is no specific category for 'Partnership Announcement' or 'Major Contract Award', and it is not a director dealing (DIRS), capital change (CAP/SHA), or dividend notice (DIV), it falls best under the general regulatory announcement category, 'Regulatory Filings' (RNS), as it is information the company is required to make public according to securities acts mentioned at the end ("The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act.").
2014-05-07 English
Elekta ingår strategiskt samarbete med Centre Hospitalier de l'Université de Montréal
Regulatory Filings Classification · 1% confidence The document is a press release announcing a strategic collaboration and a significant order (over USD 20 million) for cancer treatment equipment and software between Elekta and a Canadian hospital (CHUM). It details the products involved (Elekta Infinity, MOSAIQ) and includes quotes from management. The final paragraph states: "Informationen är sådan som Elekta AB (publ) ska offentliggöra enligt lagen om handel med finansiella instrument och/eller lagen om värdepappersmarknaden. Informationen lämnades för offentliggörande den 7 maj, 2014 kl. 07:30 CET." This structure strongly suggests a mandatory regulatory disclosure related to a material event, which often falls under general regulatory announcements or specific categories like M&A or Capital if applicable. Since this is a major contract announcement that doesn't fit neatly into ER, IR, CAP, or TAR, and it is explicitly framed as information that must be made public according to financial instrument laws, the most appropriate general category for significant, non-standard regulatory news is RNS (Regulatory Filings). It is not a full report (10-K, IR), a management discussion (MDA), or an earnings release (ER).
2014-05-07 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.